AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06519838 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inferior alveolar nerve block technique
Description: While the mouth is opened as wide as possible, the index finger palpates the external oblique ridge reaching the Coronoid notch. A 27-gauge long dental needle will be used for injection. The needle will be directed between the two primary molars on the opposing side of the arch, penetrating the tissues at the point halfway between coronoid notch and the pterygomandibular raphe at the occlusal plane level or slightly lower.The needle is withdrawn 2mm to aspirate. Once negative aspiration is checked, the remainder of the solution is deposited slowly. Approximately 1.0 mL of LA will be delivered near the inferior alveolar nerve. The average depth of insertion is about 15mm, which is nearly two-thirds the needle length.
Study NCT04751695 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CoronoVac Vaccine
Description: CoronaVac vaccines will be inoculated in 2 doses with an interval of 24 days.
Study NCT05679245 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment for exposure to psychological trauma and related symptoms
Description: To be assessed for exposure to traumatic life events, post-traumatic stress disorder, trauma-related symptoms, dissociative symptoms, affective symptoms, and psychosocial functioning.
Study NCT06073457 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MagGJ System
Description: Anastomoses achieved by magnetic compression.
Study NCT05343169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Overdose Education and Naloxone Distribution
Description: Education on OD risk behaviors and methods for responding to an OD, including naloxone use.~Duration and dose: Single 20-minute training at time of enrollment, provided to all participants in both arms
Study NCT05343169 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Overdose Education and Naloxone Distribution
Description: Education on OD risk behaviors and methods for responding to an OD, including naloxone use.~Duration and dose: Single 20-minute training at time of enrollment, provided to all participants in both arms
Study NCT05343169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Advanced Education in Safer Substance Use, Treatment, and Self-Care
Description: Education about misinformation about OAT, self-care, SEP services, HIV/HCV treatment Duration/dose: 9 mos., monthly \~2 hr. group sessions + ongoing access to video archive of recorded trainings.
Study NCT05343169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Service and Health Navigation
Description: Help navigate access and barriers to healthcare, motivation and health goals Duration/dose: 9 mos., monthly face-to-face sessions to set goals and schedule appts, phone calls between sessions > 1x/wk.
Study NCT05343169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer Social Support
Description: Support with social (re)integration, isolation, relationship building Duration/dose: 9 mos., monthly face-to-face events and phone calls/texts between sessions > 1x/wk.
Study NCT06233890 — intervention group
Intervention type: DEVICE
Intervention: Motion watch
Description: Actigraphy watch to be worn for 14 days
Study NCT06532734 — intervention group
Intervention type: DEVICE
Intervention: EsoGuard
Description: device used to collect esophageal cell samples to test for the presence of abnormal cells which may indicate a dx of Barrett's esophagitis.
Study NCT05512689 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ventilations while using a respiratory function monitor
Description: Healthcare professionals are able to use a feedback device to guide their ventilations.
Study NCT06024434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises
Description: Experimental Group Exercises for Core: Crunches, Glute bridges Crunches Glute bridge Week 1-2 (set/rep/sec) Week 3-4 (set/rep/sec) Week 5-6 (set/rep/sec) Exercises for upper body: Push up (4), Bicep curls Exercises Weeks Reps/sets Push up walk out Bicep curls 1-3 16-20\*3 Push up Bicep curl with Dumbbell 4-6 12-15\*3 Exercises for Lower body: Lunges and Squats Exercises Weeks Reps/set Split Squat with body weight Body weight Squat 1-3 16-20\*3 Split Squat with Dumbbell Squat with Dumbbell 4-6 12-15\*
Study NCT06024434 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Walking
Description: Walking for 30min, 5 days a week
Study NCT05616676 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief digital imagery-competing task
Description: First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.~Option to engage in self-administered/guided sessions after the first session.
Study NCT05616676 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief digital music-listening task
Description: First session guided by a researcher: Information about the composer's music followed by listening to classical music.~Option to engage in self-administered/guided sessions after the first session.
Study NCT05616676 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment As Usual
Description: Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
Study NCT04940156 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Confirm Rx (Implantable Cardiac Monitor)
Description: Confirm Rx implanted in patients with atrial fibrillation detected on their cardiac implantable electronic device (CIED)
Study NCT04940156 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Reveal LINQ (Implantable Cardiac Monitor)
Description: Reveal LINQ implanted in patients with atrial fibrillation detected on their cardiac implantable electronic device (CIED)
Study NCT04862260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cholesterol metabolism disruption
Description: Cholesterol metabolism disruption using a combination of atorvastatin, ezetimibe and evolocumab in metastatic pancreatic adenocarcinomas
Study NCT04235400 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: No Dye BreakUp Time
Description: Measurement without dye of the tear meniscus height (TMH) which give an rapid hint on the quantity of tears present on the ocular surface, the measure in real time of the tear osmolarity and, at last, the analysis of the thickness of the tear's layer by interferometry (measurement of the light fringes reflected by the tears when illuminated with polarized light, whereby the complete layer or the lipid layer alone can be evaluated separately depending on the machines used) and of the assessment of the quality of the Meibomian glands (non-contact imaging by infrared illumination).
Study NCT06380205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Povorcitinib
Description: Povorcitinib will be administered at protocol defined dose.
Study NCT06380205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levonorgestrel/Ethinyl estradiol
Description: Levonorgestrel/Ethinyl estradiol will be administered at protocol defined dose.
Study NCT03714477 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy
Description: A minimally invasive treatment for renal stone which was first introduced in early 1980's. It tries to fragment the renal stones by high-energy shockwave at the kidney from the outside.
Study NCT05710146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: 1 injection of 15mg/kg of TXA in 100mL of normal saline
Study NCT05710146 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 injection of 100mL of normal saline
Study NCT03902093 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Morphology changes with extended wear hearing aid
Description: Possible changes in morphology due to wearing an extended wear hearing aid device will be assessed with imaging
Study NCT06017401 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Oblique Subcostal Transversus Abdominis Plane Block
Description: The investigator will perform oblique subcostal transversus abdominis plane block to that patient group for postoperative analgesia
Study NCT06017401 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transmuscular Quadratus Lumborum Block
Description: The investigator will perform transmuscular quadratus lumborum block to that patient group for postoperative analgesia
Study NCT05914818 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EXPLORER V2
Description: 4 sessions of use of the exoskeleton, 1 in a laboratory of gait analysis and 3 in the home and the community of the participants
Study NCT04826159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMB-1018972
Description: Modified release tablet for oral administration
Study NCT06133140 — intervention group
Intervention type: DEVICE
Intervention: Unblinded postoperative vital sign monitoring
Description: Unblinded postoperative GE Portrait monitoring
Study NCT06133140 — intervention group
Intervention type: DEVICE
Intervention: Blinded postoperative vital sign monitoring
Description: Blinded postoperative GE Portrait monitoring
Study NCT06422169 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ArToFILL
Description: ArToFILL is an injectable medical device (class III) intended for use as a temporary filler in joints. It is a sterile, non-pyrogenic, colorless and transparent hyaluronic acid gel of non-animal origin. ArToFILL is a hydrogel consisting of a mixture of two different molecular weights of hyaluronic acid, for a total HA concentration of 2.7 %.
Study NCT05118347 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Buteyko Breathing Technique
Description: An incentive spirometer is a device that measures how deeply you can inhale (breathe in). It helps you take slow, deep breaths to expand and fill your lungs with air. This helps prevent lung problems, such as pneumonia. The incentive spirometer is made up of a breathing tube, an air chamber, and an indicator.
Study NCT05852314 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally Adapted Manual Assisted Therapy (CMAP-SI)
Description: C-MAP has been adapted from a self-help guide called Life After Self-Harm based on the principles of CBT. It is a brief problem-solving therapy comprising have 4 sessions weekly and then 4 fortnightly and last about 50 minutes each. The manual has been translated to Urdu giving special consideration to cultural adaptation of phrases and concepts to reflect Pakistani culture. Additionally, culturally appropriate case scenarios were incorporated and a consensual view to addressing cultural factors such as gender role, family conflicts and financial difficulties was taken. The culturally adapted intervention consists of the following components: evaluation of self-harm attempt, crisis skills, problem-solving and CBT techniques to manage emotions, negative thinking, interpersonal relationships, and relapse prevention strategies. Participants will receive sessions according to adapted CMAP-SI manual.
Study NCT05216445 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Training
Description: The Mindfulness Training will be an 8-week course, with group-based online weekly sessions. The mindfulness training, translated and adapted in Urdu, includes 8 guided audio meditations and one introductory audio recording which gives the participants an overview and introduction of the forthcoming 8-week training (e.g what mindfulness is, some common terms used repeatedly). It also includes 8 chapters, corresponding to each week and a workbook to record home practice. The training will start with an online group session after which the participants will be emailed the 1st week's reading material (chapter 1), audio recordings (for that week), home practice (for that week). At the start of every week, the participants will be emailed the required material for that week. Online sessions will be conducted weekly. The participants will also be sent poems and/or quotations relating to the week's theme and based on the session proceedings.
Study NCT05269368 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wicking
Description: Absorbable or non-absorbable wicking
Study NCT05269368 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: No wicking
Description: No wicking after surgery
Study NCT06203821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NP137
Description: NP137 for the Treatment of Resectable Pancreatic Cancer
Study NCT04611542 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fathering In Recovery
Description: Fathering In Recovery (FIR) will be designed to address the unique needs of fathers in treatment for opioid misuse. FIR integrates evidence-based parenting interventions that have well-documented positive outcomes on children, parents, and families, with innovative web-based mobile technology to maximize accessibility, fidelity, and consistency of intervention and support.
Study NCT05720559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin via intravenous drip on d1 at a dose of 130mg/m2 × patient 's body surface area
Study NCT05720559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S1
Description: Orally on d2-d15 at 20 mg three times daily
Study NCT05720559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Cetuximab combined with chemotherapy was administered simultaneously, once every three weeks,and intravenous drip was performed before oxaliplatin at a dose of 250 mg/m2 × body surface area.
Study NCT05720559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: Metronidazole 0.4g/time, qd
Study NCT05720559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin A
Description: Vitamin A 25,000 units/time, qd
Study NCT05720559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Folic acid
Description: Folic acid 0.4 mg/time, qd
Study NCT05720559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine via orally on d2-d15 two times daily at a dose of 1000mg/m2 × patient 's body surface area.
Study NCT06344715 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SL-T10
Description: A therapeutic DNA vaccine containing three prostate cancer-specific antigen genes and genetic adjuvants
Study NCT06344715 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GX-I7
Description: A T-cell growth factor
Study NCT06344715 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: An immune check point inhibitor
Study NCT05170815 — intervention group
Intervention type: PROCEDURE
Intervention: Spine surgery
Description: Implantation of spine Interbody Fusion Devices and/or Posterior fixation System.
Study NCT05441033 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group-FHB
Description: This is the group where pregnant women and their spouses listen to the fetal heartbeat.
Study NCT05441033 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group-GIT
Description: This is the group in which the guided imagery technique is applied to pregnant women and their spouses.
Study NCT05912205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Disitamab Vedotin
Description: Four cycles of neoadjuvant therapy with Vidiximab (2.0mg/kg) were administered first, followed by bladder sparing therapy using maximized TURBT combined with radiotherapy and chemotherapy. The patient will receive vidiximab combined with local radiotherapy after maximizing TURBT surgery. The subjects received treatment with Vidixitol every two weeks for six consecutive treatment cycles, and simultaneously received 1 month of radiation therapy (SBRT, total dose of bladder irradiation field greater than 50 Gy)
Study NCT05912205 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: radiotherapy
Study NCT04954092 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Gam-COVID-vac M
Description: The vaccine consists of two components: component I and component II. Component I includes a recombinant adenoviral vector based on human adenovirus serotype 26 carrying the gene for the S-protein of the SARS-CoV-2 virus, component II includes a vector based on human adenovirus serotype 5 carrying the protein S gene of the SARS-CoV-2 virus
Study NCT04954092 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Composition without active ingredients
Study NCT04589481 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intake of 3 different candies against bad breath
Description: Intake of 3 different candies against bad breath on three different days (2-days interval each) after artificially creating a temporary bad breath (by eating of chips and cheese); analysis of breathing during intake of candy both subjectively and objectively
Study NCT05141552 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10Mg Tab
Description: In both group, subjects keep blood purification and anti heart failure treatment, including ARNI, RASi, Aldosterone inhibitors and beta receptor blocker.
Study NCT05650762 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cinesteam
Description: Cinnamon-based Secondary dressing
Study NCT04289428 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Point of Care ALT
Description: Point of Care ALT from finger-stick whole blood
Study NCT04289428 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Xpert® HBV DNA point of care assay from dried blood spot
Description: Xpert® HBV DNA point of care assay from dried blood spot
Study NCT04914715 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive High Frequency Oscillatory Ventilation
Description: We are planning to use (Medin-CNO) for non-invasive ventilation. This machine has option to deliver NHFOV with frequency of 5-20 (300-1200 breathe/min), Amplitude of 1-10, flow1-17.5 liter/min, fiO2 21-100% and integrated pressure triggered sensitivity option.
Study NCT04914715 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Invasive Ventilation
Description: Invasive ventilation will be started following endotracheal intubation, mode will be selected as Synchronized Intermittent Mandatory ventilation (SIMV) with rate of 25-60 breath/min, flow of 8 liter, positive inspiratory pressure (PIP) of 14-25, Positive end expiratory pressure (PEEP) 4-5, fio2 of 21-40.
Study NCT06201273 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training
Description: This High-Intensity Interval Training (HIIT) program, structured to span 12 weeks, incorporates three sessions per week. Each session comprises 8 to 10 exercise intervals on a cycle ergometer. During these intervals, participants are required to reach an intensity level between 8 and 10 points, based on the modified Borg scale, which ranges from 1 to 10 points. A typical interval involves 1 minute of intensive pedaling, followed by a 2-minute rest period without any activity. To facilitate progressive development, the resistance of the cycle ergometer will be adjusted biweekly to increase the pedaling challenge. Despite these adjustments, participants should consistently maintain their effort intensity within the 8 to 10 point range on the modified Borg scale for each interval.
Study NCT06201273 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance Training
Description: This training protocol, spanning a duration of 12 weeks, consists of three weekly sessions. In each session, participants will engage in Elastic Resistance Exercises (ERE) using Theraband CLX elastic bands. The focus will be on both concentric and eccentric contractions, maintaining an intensity level of 8 to 10 as per the OMNI-RES scale. Each exercise will be conducted for 1 minute, followed by a 2-minute rest period. Each exercise will be repeated three times within the session.~The specific exercises include bicep curls, seated horizontal rows, and wide squats. To ensure proper progression and adaptation, the exercise load will be adjusted biweekly. This adjustment will be based on the physiological adaptations of the subjects to the training, aiming to recalibrate the loads to new resistance thresholds and maintain a consistent intensity of 8 to 10 on the OMNI-RES scale for each exercise.
Study NCT05017584 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine
Description: The dose for the first subject (A#X) will be 12 mg 0.75% hyperbaric bupivacaine. Two possible outcomes will be recorded: satisfactory or unsatisfactory anesthesia which is determined by occurrence of intraoperative pain and the need for intraoperative analgesia supplementation. Satisfactory analgesia will be defined as a sensory block to the T8 dermatome and the patient shall require no further supplementation for discomfort during her procedure. Unsatisfactory analgesia will be defined as a block not achieving a T8 dermatomal level or when a patient requests additional medication for discomfort at any time during her procedure.~The dose for the next (A#X+1) will be adjusted based on the outcome from previous subjects respectively using up-down sequential allocation method with a biased-coin design. This process will continue in similar fashion with dose adjustments for next subjects to be based on outcome from subjects immediately prior.
Study NCT06545383 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic Neuromuscular Stabilization Exercises
Description: Exercises will last 45 minutes and will be 3 days a week for 6 weeks. Additionally DNS exercises will be performed in 40-minute sessions, 2 days a week for 6 weeks.
Study NCT06545383 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Exercises will last 45 minutes and will be 3 days a week for 6 weeks. Additionally, the control group will be asked to walk at moderate intensity for 40 minutes, 2 days a week, for 6 weeks.